A team of scientists from the United States has recently revealed how interactions between the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid protein and the double-stranded RNA motifs impart distinct droplet properties that can support multiple viral functions. The study is currently available on the bioRxiv* preprint server.
This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources
Background
Cellular macromolecules undergo liquid-liquid phase separation to condense and form droplets that are known to facilitate many cellular functions. During the viral lifecycle, many viral proteins and nucleic acids are known to undergo liquid-liquid phase separation to support vital functions, including replication.
To reduce chemical complexity and get new information about the viral liquid-liquid phase separation process, many viral models have been developed that involve one genomic nucleic acid and one protein to promote liquid-liquid phase separation.
Regarding SARS-CoV-2 nucleocapsid, it is known that the protein exhibits lower critical solution temperature (LCST) behavior and that viral RNA regulates the temperature at which nucleocapsid undergo liquid-liquid phase separation.
In the current study, the scientists have modified the RNA sequence and structure to decipher RNA characteristics that specify liquid-liquid phase separation for SARS-CoV-2 nucleocapsid protein and genomic RNA. Specifically, they have investigated how viral nucleocapsid interacts with viral RNA to initiate liquid-liquid phase separation.
Important observations
The study findings reveal that two separate and distinct double-stranded RNA motifs are recognized by two RNA-binding domains (RBD1 and RBD2) of SARS-CoV-2 nucleocapsid to promote liquid-liquid phase separation. Specifically, RBD1 interacts with transcription-regulating sequence (TRS) in an RNA structure-dependent manner, and RBD2 interacts with double-stranded RNA in a sequence-independent manner. The interaction between RBD2 and double-stranded regulates the LCST behavior of nucleocapsid. Collectively, these interactions are vital for specifying the temperature required for liquid-liquid phase separation.
Importantly, the patterning of protein – RNA interactions regulate liquid-liquid phase separation to specify the rate of condensation, the efficiency of RNA translation, and genome condensation.
Nucleocapsid – RNA interactions in SARS-CoV-2 infection
The study findings provide a mechanism by which nucleocapsid triggers a cascade of events required to establish SARS-CoV-2 infection.
Upon viral entry into host cells, the nucleocapsid protein dissociates from the condensed genome because of low initial protein concentration. This leads to the initiation of protein translation. With the progression of infection, a shift from translation to single genome packaging occurs because of nucleocapsid accumulation. This subsequently stops the production of non-structural proteins while sparing sub-genomic RNAs that are required for the production of nucleocapsid and other structural proteins. The presence of high affinity nucleocapsid binding sites at genome ends may facilitate liquid-liquid phase separation-mediated circularization to induce single genome packaging.
Within the double membrane vesicles, complexes of RNA and nucleocapsid form, and the condensed genome gradually matures to form virions. The recruitment of nucleocapsid to low affinity genome sites is driven by high protein concentration within the vesicles.
Although the length of double-stranded RNA is crucial for RBD2 – RNA interaction, the primary sequence specificity of the stem-loops is not vital for the interaction. Extreme differences in stem-loop lengths can alter the temperature encoding behavior, with 20 – 24 nucleotide double-stranded RNA inducing liquid-liquid phase separation at 37°C and addition double-stranded RNA reducing the temperature to as low as 25°C.
Based on the study findings, the most efficient binding sites for RBD2 are the well-structured stem loops at the genome end. Such interactions facilitate liquid-liquid phase separation at normal body temperature (37°C). Binding to RBD2 at 37°C facilitates the dissolution of the RBD2 dimerization domain, and temperature-dependent unfolding of this domain is vital to the LCST behavior of nucleocapsid protein.
Furthermore, the study findings indicate that specific pattering of the genomic RNA sequence or structure determines nucleocapsid interactions to promote RNA genome condensation or packaging. Although nucleocapsid readily forms large droplets in cells, the genome is instead packed into regularly-spaced protein – RNA complexes that may be arrested in coarsening.
Study significance
The study reveals that the sequence and structural specificity of double-stranded RNA determines the liquid-liquid phase separation behavior of SARS-CoV-2 nucleocapsid protein. Moreover, the study demonstrates how complex interactions between viral protein and RNA determine the kinetics, properties, and temperature at which protein droplets can form.
This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources
Article Revisions
- Apr 10 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Psilocybin therapy reduces depression in clinicians after pandemic frontline work